mardi 7 juillet 2015

Onco Actu du 7 juillet 2015

3.1 Tabac

WHO urges governments to raise tobacco taxes to beat smoking [Reuters]

4.1 Dép., diag. & prono. - Prostate

Op-Ed Contributor: Bring Back Prostate Screening [NY Times]

4.12 Biopsies liquides

A Perfect Blood Test For Pancreatic Cancer? [Forbes]

4.2 Dép., diag. & prono. - Génome

Who should we screen for the BRCA gene? [Cancer World]

4.9 Dép., diag. & prono. - Sein

Screening mammograms don't prevent breast cancer deaths, study finds [LA Times]

Mammograms may not reduce breast cancer deaths [Reuters]

5. Traitements

Pazopanib improves progression-free survival without impairing health-related quality of life [EORTC]

5.2 Pharma

Eli Lilly preps a familiar case for FDA review of a marginal cancer drug [FierceBiotech]

Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamous cell carcinoma of the lung [Boehringer Ingelheim]

Daratumumab Expanded Access Program Open to Eligible U.S. Patients with Heavily Pre-Treated Multiple Myeloma [Johnson & Johnson]

5.2.3 Pharma - économie

Greek Crisis Prompts Industry Clash Over Drug Prices and Supplies [Wall Street Journal]

5.3 Traitements - FDA, EMA,...

Serious Risks And Few New Benefits From FDA-Approved Drugs [Health Affairs Blog]

5.3.4 Traitements - AMM (FDA, EMA)

Improving safety of medicines across Europe [EMA]

European Medicines Agency Recommends Granting a Marketing Authorisation for Docetaxel Hospira UK Limited [ESMO]

5.4 Traitements - Economie

Is There a Breaking Point for Immunotherapy Costs? [The OBR Blog]

5.5 ASCO

ASCO Endorses ASTRO Guideline on Radiation Therapy After Surgery for Endometrial Cancer [ASCO]

5.6 ESMO

ArQule Announces Interim Phase 2 Study Results for Tivantinib in Combination with Cetuximab in Patients with MET-High, KRAS Wild Type Colorectal Cancer Presented at ESMO World Congress on Gastrointestinal Cancer 2015 [ArQule]

6.1 Observation

Things are getting better, not worse, when it comes to cancer [The Incidental Economist]

6.4 Médico-éco

Prescribing in England up 55% to £9bn over a decade [Pharmafile]

6.6 Publications

Cancer Research retraction is fifth for Robert Weinberg; fourth for his former student [Retraction Watch]